____________________________________________________________
Programme
____________________________________________________________
| Time | Session/Presenter/Topic |
| 09:00 - 13:00 | Screening Programmes The Italian Experience - Emanuele Bosi, Milan The US Experience - Marian Rewers, Denver, Colorado ELSA - Lauren Quinn, Birmingham T1DRA - Kathleen Gillespie - Bristol UK National Screening Committee POV - TBC A patient experience of screening - 10 mins for family and adult (ELSA, T1DRA) Panel discussion on implementing screening in the UK: PCDS, UKNSC, Patient, all speakers Screening Process Optimising Ab assays for T1D screening – Alex Richter, Birmingham How can genetic analysis support the identification of children and adults with pre-symptomatic T1D? – Richard Oram, Exeter Parallel ‘meet the expert’ sessions in breakout rooms a) Screening programmes or b) The screening process |
| 13:00 - 14:00 | LUNCH |
| 14:00 - 17:00 | Research studies into Monitoring of pre-T1D Current UK Research Monitoring studies in Children: Loredana Marcovecchio, Cambridge Current UK Research Monitoring studies in Adults: Anna Long, Bristol Managing pre-T1D in UK clinical practice Monitoring children in UK clinical practice and the UK Ab Registry: Rachel Besser - Oxford Accurate disease classification and monitoring of pre-T1D in adults: Nick Thomas - Exeter Panel Discussion with Marc Atkin, Fulya Mehta, led by Fiona Campbell, Parth Narendran Parallel ‘meet the expert’ sessions in breakout rooms a) Running a pre-T1D service in paediatrics (RD/RB) or b) Running a pre-T1D service in adults (NT/PN) |
| Time | Session/Presenter/Topic |
| 09:00 - 13:00 | The psychological impact of early detection T1D detection Summary of evidence so far - Olga Boiko, Birmingham Peer support - Ian Litchfield, Birmingham New ways to assess impact - TBC Panel discussion led by Felicity Boardman with all speakers Disease Modifying Therapy for T1D Lessons from MS - Gavin Giovannoni, London The US Experience - Kimber Simmons, Denver The UK Experience - Renuka Dias, Birmingham and Neil Wright, Sheffield Experience of a local family - TBC Navigating the practicalities of accessing and delivering a 14-day therapy - Phil Newland Jones, Southampton Early finding from the NHS FIT study of DMT therapy in the UK - Matthew Randell, Warwick |
| 13:00 - 14:00 | LUNCH |
| 14:00 - 17:00 | The Future Pipeline of DMTs in T1D - TBC The T1DRC, Platform trials and the future - Colin Dayan - Cardiff Close and Departure |